Gene polymorphism of neurotransmitter transporters in schizophrenic patients with drug-induced hyperprolactinemia

Boiko, A. S., Osmanova, D., Pozhidaev, I., Fedorenko, O., Ivanova, S. A., Semke, A., Bokhan, N. & Loonen, A. J. M. Oct-2016 In : European Neuropsychopharmacology. 26, Supplement 2, p. S510-S511 2 p.

Research output: Other research outputMeeting Abstract

  • A.S. Boiko
  • D. Osmanova
  • I. Pozhidaev
  • O. Fedorenko
  • S.A. Ivanova
  • A. Semke
  • N. Bokhan
  • A.J.M. Loonen
Original languageEnglish
Pages (from-to)S510-S511
Number of pages2
JournalEuropean Neuropsychopharmacology
Issue numberSupplement 2
StatePublished - Oct-2016
Event29th Congress of the European-College-of-Neuropsychopharmacology (ECNP) - Vienna, Austria


29th Congress of the European-College-of-Neuropsychopharmacology (ECNP)


Vienna, Austria

Event: Conference


  • dopamine, dopamine transporter, endogenous compound, neuroleptic agent, neurotransmitter transporter, noradrenalin, noradrenalin transporter, prolactin, serotonin, vesicular monoamine transporter, adult, adverse drug reaction, analyzer, chi square test, controlled study, data analysis software, diagnosis, drug therapy, enzyme linked immunosorbent assay, female, gender, gene expression, gene frequency, gene mutation, genetic marker, genetic susceptibility, genotype, human, hyperprolactinemia, major clinical study, male, neurotransmission, normal human, paranoid schizophrenia, pharmacogenetic testing, prevalence, quality of life, Russian (people), Russian Federation, side effect, single nucleotide polymorphism

View graph of relations

ID: 39446469